22
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      TEX264 coordinates p97- and SPRTN-mediated resolution of topoisomerase 1-DNA adducts

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Eukaryotic topoisomerase 1 (TOP1) regulates DNA topology to ensure efficient DNA replication and transcription. TOP1 is also a major driver of endogenous genome instability, particularly when its catalytic intermediate—a covalent TOP1-DNA adduct known as a TOP1 cleavage complex (TOP1cc)—is stabilised. TOP1ccs are highly cytotoxic and a failure to resolve them underlies the pathology of neurological disorders but is also exploited in cancer therapy where TOP1ccs are the target of widely used frontline anti-cancer drugs. A critical enzyme for TOP1cc resolution is the tyrosyl-DNA phosphodiesterase (TDP1), which hydrolyses the bond that links a tyrosine in the active site of TOP1 to a 3’ phosphate group on a single-stranded (ss)DNA break. However, TDP1 can only process small peptide fragments from ssDNA ends, raising the question of how the ~90 kDa TOP1 protein is processed upstream of TDP1. Here we find that TEX264 fulfils this role by forming a complex with the p97 ATPase and the SPRTN metalloprotease. We show that TEX264 recognises both unmodified and SUMO1-modifed TOP1 and initiates TOP1cc repair by recruiting p97 and SPRTN. TEX264 localises to the nuclear periphery, associates with DNA replication forks, and counteracts TOP1ccs during DNA replication. Altogether, our study elucidates the existence of a specialised repair complex required for upstream proteolysis of TOP1ccs and their subsequent resolution.

          Abstract

          Eukaryotic topoisomerase 1 (TOP1) regulates DNA topology to ensure efficient DNA replication and transcription. Here, the authors reveal insights into the molecular resolution of topoisomerase 1-DNA adducts by TEX264, p97 and SPRTN.

          Related collections

          Most cited references59

          • Record: found
          • Abstract: found
          • Article: not found

          Analysis of protein dynamics at active, stalled, and collapsed replication forks.

          Successful DNA replication and packaging of newly synthesized DNA into chromatin are essential to maintain genome integrity. Defects in the DNA template challenge genetic and epigenetic inheritance. Unfortunately, tracking DNA damage responses (DDRs), histone deposition, and chromatin maturation at replication forks is difficult in mammalian cells. Here we describe a technology called iPOND (isolation of proteins on nascent DNA) to analyze proteins at active and damaged replication forks at high resolution. Using this methodology, we define the timing of histone deposition and chromatin maturation. Class 1 histone deacetylases are enriched at replisomes and remove predeposition marks on histone H4. Chromatin maturation continues even when decoupled from replisome movement. Furthermore, fork stalling causes changes in the recruitment and phosphorylation of proteins at the damaged fork. Checkpoint kinases catalyze H2AX phosphorylation, which spreads from the stalled fork to include a large chromatin domain even prior to fork collapse and double-strand break formation. Finally, we demonstrate a switch in the DDR at persistently stalled forks that includes MRE11-dependent RAD51 assembly. These data reveal a dynamic recruitment of proteins and post-translational modifications at damaged forks and surrounding chromatin. Furthermore, our studies establish iPOND as a useful methodology to study DNA replication and chromatin maturation.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Intrinsically Disordered Protein TEX264 Mediates ER-phagy

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy.

              Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs covalently bound topoisomerase I-DNA complexes and is essential for preventing the formation of double-strand breaks that result when stalled topoisomerase I complexes interfere with DNA replication in yeast. Here we show that a deficiency of this DNA repair pathway in humans does not predispose to neoplasia or dysfunctions in rapidly replicating tissues, but instead causes spinocerebellar ataxia with axonal neuropathy (SCAN1) by affecting large, terminally differentiated, non-dividing neuronal cells. Using genome-wide linkage mapping and a positional candidate approach in a Saudi Arabian family affected with autosomal recessive SCAN1, we identified a homozygous mutation in TDP1 (A1478G) that results in the substitution of histidine 493 with an arginine residue. The His493 residue is conserved in TDP1 across species and is located in the active site of the enzyme. Protein modeling predicts that mutation of this amino acid to arginine will disrupt the symmetric structure of the active site. We propose that loss-of-function mutations in TDP1 may cause SCAN1 either by interfering with DNA transcription or by inducing apoptosis in postmitotic neurons.
                Bookmark

                Author and article information

                Contributors
                kristijan.ramadan@oncology.ox.ac.uk
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                9 March 2020
                9 March 2020
                2020
                : 11
                : 1274
                Affiliations
                [1 ]ISNI 0000 0004 1936 8948, GRID grid.4991.5, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, , University of Oxford, ; Oxford, OX3 7DQ UK
                [2 ]ISNI 0000 0004 1936 9262, GRID grid.11835.3e, The University of Sheffield Neuroscience Institute and the Healthy Lifespan Institute, Department of Molecular Biology and Biotechnology, Firth Court, , University of Sheffield, ; S10 2TN Sheffield, UK
                [3 ]ISNI 0000 0000 9826 9219, GRID grid.411220.4, Unidad de Investigación, , Hospital Universitario de Canarias, Ofra s/n, La Cuesta, ; 38320 La Laguna, Tenerife Spain
                [4 ]ISNI 0000000121060879, GRID grid.10041.34, Instituto de Tecnologías Biomédicas, , Universidad de La Laguna, ; 38200 La Laguna, Tenerife Spain
                [5 ]Universidad Fernando Pessoa Canarias, 35450 Las Palmas de Gran Canaria, Spain
                [6 ]ISNI 0000 0004 1936 8948, GRID grid.4991.5, TDI Mass Spectrometry Laboratory, Target Discovery Institute, Nuffield Department of Medicine, , University of Oxford, ; Oxford, UK
                Author information
                http://orcid.org/0000-0003-4283-0283
                http://orcid.org/0000-0003-4417-0370
                http://orcid.org/0000-0003-4473-8894
                http://orcid.org/0000-0003-4390-8767
                http://orcid.org/0000-0002-9715-5951
                http://orcid.org/0000-0002-8160-2446
                http://orcid.org/0000-0003-2721-7763
                http://orcid.org/0000-0001-5522-021X
                Article
                15000
                10.1038/s41467-020-15000-w
                7062751
                32152270
                f40dbe0a-f842-4689-84f5-f5722de6e735
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 7 November 2019
                : 16 February 2020
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100000265, RCUK | Medical Research Council (MRC);
                Award ID: MC_EX_MR/K022830/1
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100000289, Cancer Research UK (CRUK);
                Funded by: FundRef https://doi.org/10.13039/100004410, European Molecular Biology Organization (EMBO);
                Award ID: ALTF 1109-2017
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s) 2020

                Uncategorized
                dna,proteolysis
                Uncategorized
                dna, proteolysis

                Comments

                Comment on this article